At the Intersection of Science and LawAI risk assessments: Future-proofing your innovation when rules can change mid-game
Published in Chambers Expert Focus. DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and pharmaceutical companies are future-proofing their innovations in artificial intelligence as new regulations and risks arise.
In 1 playlist(s)
At the Intersection of Science and Law
In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences t…Social links
Follow podcast
Recent clips
Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
29:37
Life sciences companies and the risks posed by the mifepristone litigation
33:17
Trade secrets protection in the life sciences sector
21:22